Select Bancorp Inc (SLCT)

18.88  -0.47 (-2.43%)

After market: 18.7 -0.18 (-0.95%)

Fundamental Rating

2

Overall SLCT gets a fundamental rating of 2 out of 10. We evaluated SLCT against 411 industry peers in the Banks industry. Both the profitability and financial health of SLCT have multiple concerns. SLCT shows excellent growth, but is valued quite expensive already.



0

1. Profitability

1.1 Basic Checks

In the past year SLCT was profitable.

1.2 Ratios

Industry RankSector Rank
ROA 0.98%
ROE 8.28%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Operating Margin and Gross Margin are not available for SLCT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 26.98%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

SLCT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

SLCT has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 141.86% over the past year.
Measured over the past years, SLCT shows a decrease in Earnings Per Share. The EPS has been decreasing by -4.28% on average per year.
Looking at the last year, SLCT shows a very strong growth in Revenue. The Revenue has grown by 28.65%.
SLCT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.10% yearly.
EPS 1Y (TTM)141.86%
EPS 3Y-10.94%
EPS 5Y-4.28%
EPS growth Q2Q700%
Revenue 1Y (TTM)28.65%
Revenue growth 3Y15.94%
Revenue growth 5Y12.1%
Revenue growth Q2Q35.05%

3.2 Future

Based on estimates for the next years, SLCT will show a very strong growth in Earnings Per Share. The EPS will grow by 22.20% on average per year.
SLCT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.56% yearly.
EPS Next Y196.91%
EPS Next 2Y61.14%
EPS Next 3Y41.84%
EPS Next 5Y22.2%
Revenue Next Year28.16%
Revenue Next 2Y14.97%
Revenue Next 3Y12.82%
Revenue Next 5Y9.56%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 18.15, the valuation of SLCT can be described as rather expensive.
When comparing the Price/Earnings ratio of SLCT to the average of the S&P500 Index (28.60), we can say SLCT is valued slightly cheaper.
A Price/Forward Earnings ratio of 15.81 indicates a correct valuation of SLCT.
The average S&P500 Price/Forward Earnings ratio is at 20.15. SLCT is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 18.15
Fwd PE 15.81

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

SLCT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SLCT's earnings are expected to grow with 41.84% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.09
PEG (5Y)N/A
EPS Next 2Y61.14%
EPS Next 3Y41.84%

0

5. Dividend

5.1 Amount

SLCT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

Select Bancorp Inc

NASDAQ:SLCT (10/15/2021, 7:05:20 PM)

After market: 18.7 -0.18 (-0.95%)

18.88

-0.47 (-2.43%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap325.30M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 18.15
Fwd PE 15.81
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.09
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.98%
ROE 8.28%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) 26.98%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio N/A
Quick Ratio N/A
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)141.86%
EPS 3Y-10.94%
EPS 5Y
EPS growth Q2Q
EPS Next Y196.91%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)28.65%
Revenue growth 3Y15.94%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y